Popiţa Anca-Raluca, Rusu Adriana, Muntean Valentin, Cadariu Patriciu Achimas, Irimie Alexandru, Lisencu Cosmin, Pop Bogdan, Resiga Liliana, Fekete Zsolt, Badea Radu
"Ion Chiricuţă" Oncology Institute, Cluj-Napoca, Romania.
Medical Imaging Department, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Med Pharm Rep. 2023 Jul;96(3):258-268. doi: 10.15386/mpr-2542. Epub 2023 Jul 27.
To evaluate the performance of magnetic resonance imaging (MRI) in restaging locally advanced rectal cancers (LARC) after neoadjuvant chemoradiotherapy (nCRT), with pathologic correlation.
80 patients with LARC treated with neoadjuvant therapy, with restaging MRI and surgery, were enrolled and prospectively reviewed. The diagnostic accuracy of the restaging MRI was assessed for tumor (ymrT), nodal status (ymrN), circumferential resection margin (ymrCRM), extramural vascular invasion (ymrEMVI) and tumoral deposits (ymrN1c) by calculating the sensitivity (Se), specificity (Sp), negative predictive values (NPV) and positive predictive values (PPV). Response to treatment was classified as good response (complete/near complete) vs. poor response (poor/partial response). The agreement between the tumor regression grade at MRI (mrTRG) and pathology (pTRG) was reported, as well the performance of mrTRG to identify good responders. The correlation between restaging MRI and histopathology was assessed by Spearman correlation coefficient.
The MRI accuracy ranged between 63.8% and 92.5% for T stage and was 81.3% for N stage. All MRI parameters evaluated at restaging were statistically significant correlated with histopathology evaluation, but EMVI. There was moderate correlation for N and N1c and a positive strong correlation for T, CRM and TRG (Spearman correlation coefficient of 0.390 for mrN1c-pN1c, 0.428 for mrN-pN, 0.522 for mrCRM-pCRM, 0.550 for mrT-pT and 0.731 for mrTRG-pTRG). Diagnostic accuracy of anal sphincter invasion was 91.3%, with a negative predictive value (NPV) of 100%. Accuracy rate varied between 70% for partial response to 93.75% for complete response after nCRT.
MR imaging had good accuracy in restaging LARCs after nCRT. Our results showed high MRI accuracy in detecting anal sphincter involvement for low rectal tumors, with high NPV to exclude tumoral invasion. Restaging MRI predicted well the tumor regression grade, with good diagnostic performance in differentiating good responders from poor/partial responders. The accuracy was high for detecting complete response.
评估磁共振成像(MRI)在新辅助放化疗(nCRT)后对局部晚期直肠癌(LARC)进行再分期的性能,并与病理结果进行对照。
纳入80例接受新辅助治疗、再分期MRI检查及手术的LARC患者,并进行前瞻性分析。通过计算灵敏度(Se)、特异度(Sp)、阴性预测值(NPV)和阳性预测值(PPV),评估再分期MRI对肿瘤(ymrT)、淋巴结状态(ymrN)、环周切缘(ymrCRM)、壁外血管侵犯(ymrEMVI)和肿瘤结节(ymrN1c)诊断的准确性。将治疗反应分为良好反应(完全/接近完全)与不良反应(不良/部分反应)。报告MRI肿瘤退缩分级(mrTRG)与病理肿瘤退缩分级(pTRG)之间的一致性,以及mrTRG识别良好反应者的性能。采用Spearman相关系数评估再分期MRI与组织病理学之间的相关性。
T分期的MRI准确率在63.8%至92.5%之间,N分期为81.3%。再分期时评估的所有MRI参数,除EMVI外,与组织病理学评估均具有统计学显著相关性。N和N1c呈中度相关,T、CRM和TRG呈强正相关(mrN1c与pN1c的Spearman相关系数为0.390,mrN与pN为0.428,mrCRM与pCRM为0.522,mrT与pT为0.550,mrTRG与pTRG为0.731)。肛门括约肌侵犯的诊断准确率为91.3%,阴性预测值(NPV)为100%。nCRT后部分反应的准确率在70%之间,完全反应的准确率在93.75%之间。
MR成像在nCRT后对LARC进行再分期时具有良好的准确性。我们的结果显示,MRI在检测低位直肠癌肛门括约肌受累方面具有较高的准确性,NPV高可排除肿瘤侵犯。再分期MRI能很好地预测肿瘤退缩分级,在区分良好反应者与不良/部分反应者方面具有良好的诊断性能。检测完全反应的准确率较高。